Ireland· IE-PA-PA1077/058/001
Flolan 1.5 mg powder and solvent for solution for infusion
A epoprostenol product containing epoprostenol, registered in Ireland by GlaxoSmithKline (Ireland) Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Epoprostenol is registered in 14 of 19 countries.
Countries holding a registration under ATC B01AC09 (epoprostenol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Epoprostenol · ATC B01AC09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Epoprostenol
- Manufacturer
- GlaxoSmithKline (Ireland) Limited
- Country
- Ireland (IE)
- ATC code
- B01AC09
- ATC class
- Epoprostenol
- Defined daily dose
- 38 mcg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1077/058/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
402 interactions on record for epoprostenol.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Epoprostenol · interactions on record
402 records
- 34 severe
- 269 moderate
- 4 minor
- 95 info
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Epoprostenol in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomEpoprostenol 1.5mg powder (pH12) for solution for infusion vialsSun Pharma UK Ltd
- BelgiumEpoprostenol Sandoz 1,5 mgSandoz
- SpainEPOPROSTENOL NORMON 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONLaboratorios Normon S.A.
- SwitzerlandVeletri 1.5mg, Pulver zur Herstellung einer InfusionslösungJanssen-Cilag AG
- CzechiaVELETRIJanssen-Cilag International N.V., Beerse
- PolandVeletriJanssen-Cilag International N.V.
- NetherlandsEpoprostenol SUN 0,5 mg, poeder voor oplossing voor infusieSun Pharmaceutical Industries Europe B.V.
- United StatesepoprostenolSun Pharmaceutical Industries, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Flolan
- Belgium · Flolan, Veletri
- Czechia · Flolan, Veletri
- Germany · Veletri
- Denmark · Flolan
- Spain · Epoprostenol Normon, Epoprostenol Sun
- France · Epoprostenol Panpharma, Veletri
- United Kingdom (Northern Ireland) · Epoprostenol Mercury Pharmaceuticals Ltd, Epoprostenol Sodium Hexal
- Greece · Veletri
- Hungary · Veletri
- Italy · Caripul, Flolan
- Luxembourg · Flolan, Veletri
- Netherlands · Epoprostenol Sun, Epoprostenol Sun Pharmaceutical Industries Europe
- Poland · Veletri
- Portugal · Epoprostenol Normon, Veletri
- Slovakia · Veletri
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcd064be-e698-4c96-9b6e-c40afdb812f8 GET /v1/drugs/bcd064be-e698-4c96-9b6e-c40afdb812f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B01AC",
"B01AC09"
],
"strength": null,
"pa_number": "PA1077/058/001",
"substances": [
"Epoprostenol"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "20/12/2000",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about epoprostenol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.